Vivo Bio Tech Balance Sheet Health
Financial Health criteria checks 2/6
Vivo Bio Tech has a total shareholder equity of ₹523.4M and total debt of ₹602.2M, which brings its debt-to-equity ratio to 115%. Its total assets and total liabilities are ₹1.2B and ₹683.0M respectively. Vivo Bio Tech's EBIT is ₹137.3M making its interest coverage ratio 1.7. It has cash and short-term investments of ₹16.0M.
Key information
115.0%
Debt to equity ratio
₹602.19m
Debt
Interest coverage ratio | 1.7x |
Cash | ₹15.98m |
Equity | ₹523.43m |
Total liabilities | ₹682.99m |
Total assets | ₹1.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 511509's short term assets (₹296.6M) exceed its short term liabilities (₹242.3M).
Long Term Liabilities: 511509's short term assets (₹296.6M) do not cover its long term liabilities (₹440.7M).
Debt to Equity History and Analysis
Debt Level: 511509's net debt to equity ratio (112%) is considered high.
Reducing Debt: 511509's debt to equity ratio has increased from 89% to 115% over the past 5 years.
Debt Coverage: 511509's debt is well covered by operating cash flow (29.1%).
Interest Coverage: 511509's interest payments on its debt are not well covered by EBIT (1.7x coverage).